High-Density Lipoproteins Reduce Endothelial-to-Mesenchymal Transition
Frank Spillmann, Kapka Miteva, Burkert Pieske, Carsten Tschöpe, Sophie Van Linthout by phase contrast pictures ( Figure II in the online-only Data Supplement). In accordance with this observation, immunofluorescence staining demonstrated less α-SMA-positive and VE-cadherin-negative HAEC, when HAEC were stimulated with TGF-β1 in the presence of HDL compared with TGF-β1 alone ( Figure 1A ). Flow cytometry further assessed that HDL downregulated the percentage of TGF-β1-induced α-SMApositive and VE-cadherin-negative HAEC by 1.6-fold (P<0.0005; Figure 1B ). In addition, TGF-β1 supplementation induced collagen I and III mRNA expression and collagen accumulation in HAEC by 5.5-fold (P<0.005), 1.7-fold (P<0.05), and 1.3-fold (P<0.001), respectively. In contrast, HDL abrogated the TGF-β1-mediated rise in collagen I and III mRNA expression and content, leading to levels not different from unstimulated basal conditions (Figure 2A-2C) . The HDL-mediated reduction in collagen content was abrogated in TGF-β1-supplemented scavenger receptor class B, type 1 (SR-BI) siRNA compared with scrambled siRNA-transfected HAEC, indicating that the HDL-mediated decrease in collagen in TGF-β1-supplemented HAEC occurred in a SR-BIdependent manner ( Figure 2D ). Furthermore, HDL induced the phosphorylation state of SR-BI downstream targets Akt and eNOS ( Figure IIIA and IIIB in the online-only Data Supplement) and raised the TGF-β1-downregulated NO levels by 1.2-fold (P<0.05) (control, 6800±570; HDL, 6200±430; TGF-β1, 4800±330; TGF-β1+HDL, 6000±310). The HDLmediated reduction of TGF-β1-induced collagen deposition in HAEC could be abrogated via the use of the phosphatidyl inositol-3-kinase inhibitor Ly294002, whereas no significant inhibition could be reached with the NO-inhibitor L-NAME (P=0.0898; Figure 
Discussion
The present study provides the first in vitro evidence that HDL reduce EndMT as documented by their capacity (1) to reduce the TGF-β1-induced transition to a spindle-shaped morphology; (2) to decrease the TGF-β1-induced α-SMA expression and collagen accumulation; and (3) to abrogate the TGF-β1-mediated loss of the endothelial cell marker VE-cadherin.
The endothelial-protective effects of HDL are well established. Low plasma HDL levels are an independent predictor of endothelial dysfunction in healthy individuals and diabetic patients. 18 In contrast, elevation of plasma HDL by niacin, infusion of synthetic HDL, 19 gene transfer with apolipoprotein (apo) A-I, 6 the main apolipoprotein of HDL, or the use of an apo A-I mimetic peptide 20 function. The HDL-mediated improvement in endothelial function involve their induction in endothelial NO production. 6, 21 Lack of NO, the main hallmark of endothelial dysfunction, 22 results in EndMT, 4 a process which relevance in the induction of cardiac fibrosis 1, 2 and in the development of heart failure with preserved ejection fraction 2, 23 follows from recent publications. TGF-β1, the primary cytokine driving fibrosis in various organs, [24] [25] [26] is a potent inducer of EndMT. In this study, we demonstrate for the first time that HDL reduce TGF-β1-induced EndMT in HAEC, as shown by the HDLmediated reduction in the transition toward spindle-shaped cells, collagen accumulation, α-SMA expression, and loss of the endothelial cell marker VE-cadherin, induced on TGF-β1 stimulation. We showed that HDL decreased the TGF-β1-induced collagen production in HAEC in a SR-BI-dependent manner, which further corroborates the findings that HDL protect the endothelium involving the SR-BI receptor. 11 In agreement, HDL induced the phosphorylation state of SR-BI downstream targets Akt and eNOS. Furthermore, the HDLmediated decline in TGF-β1-induced collagen deposition could be abrogated by phosphatidyl inositol-3-kinase blockage. However, no significant abrogation of the HDL-mediated reduction in collagen deposition could be reached by NO inhibition, despite the observation that HDL upregulated the TGF-β1-impaired NO release in HAEC. These findings suggest that the HDL-mediated induction of phosphorylated eNOS and NO production under TGF-β1 conditions is an epiphenomen and therefore not per se linked to EndMT. We further demonstrated that HDL induced inhibitory Smad7 expression and decreased the expression of the EndMT transcription factors Slug and ZEB1, 3, 27 indicative for blocking TGF-β1-SmadEndMT signaling. Though, interestingly, an induction of the EndMT transcription factor Snail was found on supplementation with HDL, suggesting a fine tuned balance between those transcription factors and their impact on EndMT.
In brief, this study supports the antifibrotic effects of HDL, 7, 28 which are less established compared with their endothelial-protective characteristics.
In conclusion, we demonstrate a novel endothelial-protective and antifibrotic effect of HDL: the reduction in EndMT. However, further in-depth investigations are needed to elucidate the exact underlying mechanisms. 
